News & Publications
On this page, you can find our publications in different disease areas and all the latest news and updates related to Porsolt.
Porsolt is attending the European Association for Cancer Research (EACR) meeting this week in Seville, Spain. We are presenting 2 posters describing how …
A really successful BIO 2022 conference in San Diego last week, consisting of a busy schedule of meetings and concluding with a …
Epilepsy remains a major area of focus and commitment for our internal development program at PORSOLT.
We recently validated two novel reference compounds in our Electrical Amygdala Kindling in vivo model: Retigabine and Perampanel (third generation drug), in keeping …
It’s great being all together again for the Porsolt semi-annual company-wide meeting. contact@porsolt.com www.porsolt.com
We are at Biomed Israel together JANVIER LABS and our other French colleagues attending as part of Business France. Please stop by …
Porsolt is thrilled to already have our third paper published for this year: “Anti-CTLA-4 and anti-PD-1 immunotherapies repress tumor progression in preclinical …
A great start to 2022 with yet another paper !!
Porsolt continues to play a significant role in research collaborations as demonstrated with the following paper just published by #Sunovion in the …
We are proud and excited to share this Nature press paper, just published by one of our scientists (Solene Pedron). The research …
Porsolt collaborates with academic institutions to enhance research programs that benefit industry and academia alike. We are excited to share a recently …
News & Updates
Categories
Archives
Recent Posts
News & Updates
Porsolt
Z.A. de Glatigné
53940 Le Genest-Saint-Isle, France
Telephone +33 2 43 69 36 07
Legal Notice
Any questions or concerns ?
CONTACT US
